본문 바로가기
KERD
논문KCI 등재

한의치료 후 진행성 암환자의 삶의 질 및 면역 관련 지표 변화: 후향적 차트 리뷰

Improvement in Quality of Life and Immune-Related Markers in Advanced Cancer Patients after Korean Medicine Treatment: A Retrospective Chart Review

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives This study investigated the impact of Korean medicine treatments on quality of life and immune-related hematologic indicators in patients with advanced cancer. Methods The study involved patients diagnosed with stage III or IV cancer who were admitted to a Korean medicine hospital from 2021 to 2024. These patients underwent quality-of-life assessments using the EORTC QLQ-C15-PAL(European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 for Palliative Care) at admission and discharge, coupled with blood tests analyzing immune markers such as NLR(neutrophil-to-lymphocyte ratio), MLR(monocyte-to-lymphocyte ratio), and PLR(platelet-to-lymphocyte ratio). Paired t-tests were conducted to compare pre- and post-treatment results. Results Among 15 patients, significant improvement was observed in total QoL scores after Korean medicine treatment (p=0.017), with notable enhancements in fatigue, weakness, and sleep quality. While trends indicated stabilization of immune markers (e.g., reduction in NLR from 3.57 to 3.23), changes were not statistically significant. Conclusions Korean medicine treatments contributed to improved QoL, particularly in alleviating fatigue and sleep disturbances. Though immune marker changes were observed, further studies with larger samples are needed to substantiate these findings.

Abstract

Objectives This study investigated the impact of Korean medicine treatments on quality of life and immune-related hematologic indicators in patients with advanced cancer. Methods The study involved patients diagnosed with stage III or IV cancer who were admitted to a Korean medicine hospital from 2021 to 2024. These patients underwent quality-of-life assessments using the EORTC QLQ-C15-PAL(European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 for Palliative Care) at admission and discharge, coupled with blood tests analyzing immune markers such as NLR(neutrophil-to-lymphocyte ratio), MLR(monocyte-to-lymphocyte ratio), and PLR(platelet-to-lymphocyte ratio). Paired t-tests were conducted to compare pre- and post-treatment results. Results Among 15 patients, significant improvement was observed in total QoL scores after Korean medicine treatment (p=0.017), with notable enhancements in fatigue, weakness, and sleep quality. While trends indicated stabilization of immune markers (e.g., reduction in NLR from 3.57 to 3.23), changes were not statistically significant. Conclusions Korean medicine treatments contributed to improved QoL, particularly in alleviating fatigue and sleep disturbances. Though immune marker changes were observed, further studies with larger samples are needed to substantiate these findings.

참고문헌 (12)

  1. Akhlaghi E, "Chemotherapy use and quality of life in cancer patients at the end of life : an integrative review", Health Qual Life Outcomes, 332(18) (2020)[DOI]
  2. Mao JJ, "Complementary and alternative medicine use among cancer survivors : a population-based study", J Cancer Surviv, 5(1), pp.8~17 (2011)[DOI]
  3. Qi F, "Chinese herbal medicines as adjuvant treatment during chemo-or radio-therapy for cancer", BioSci Trends, 4(6), pp.297~307 (2010)
  4. Lau CHY, "Acupuncture and Related Therapies for Symptom Management in Palliative Cancer Care : Systematic Review and Meta-Analysis", Medicine(Baltimore), 95(9), pp.e2901~ (2016)[DOI]
  5. Shin HS, "The Association With Recurrence in Breast Cancer Patients According to the Preoperative Blood Composition Ratio and Postoperative Pathological Results", J Breast Dis, 10(1), pp.1~11 (2022)[DOI]
  6. Han SW, "Clinical Significance of Blood Neutrophil-to-Lymphocyte Ratio in Patients with Papillary Thyroid Carcinoma"
  7. Choi HS, "Changes in neutrophil to lymphocyte ratio(NLR)during neoadjuvant treatment correlated with patients’survival", Breast Cancer, 27, pp.871~879 (2020)[DOI]
  8. Groenvold M, "The development of the EORTC QLQ-C15-PAL : a shortened questionnaire for cancer patients in palliative care", Eur J Cancer, 42(1), pp.55~64 (2006)[DOI]
  9. Ryu HS, "A Survey on Korean Medicine Doctors for Cancer Symptoms Care in Korean Medicine Treatments", J of Kor. Traditional Oncology, 22(1), pp.23~35 (2017)[DOI]
  10. Korean Medicine Clinical Practice Guideline for Cancer-Related Symptoms, "National Institute for Korean Medicine Development(NIKOM)", ~ (2021)
  11. Molassiotis A, "Acupuncture for cancer-related fatigue in patients with breast cancer : a pragmatic randomized controlled trial", J Clin Oncol, 30(36), pp.4470~4476 (2012)[DOI]
  12. Ethier JL, "Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer : a systematic review and meta-analysis", Breast Cancer Res, 19(1), pp.2~ (2017)[DOI]

관련 논문AI추천

Changes in the Laboratory Data for Cancer Patients Treated with Korean-medicine-based Inpatient Care유화승, Chong Kwan Cho, Jeung-won Yoon, Ji-Eun Shin대한약침학회 · Journal of Pharmacopuncture2014 · 제17권 제1호Pembrolizumab 면역치료를 시행 중인 비소세포성 폐암환자의 한방치료 증례보고이인, 이찬, 권정남, 김소연, 박성하, 서형범, 서희정, 심소현, 윤영주, 조임학, 최준용, 한창우, 홍진우대한한방내과학회 · 대한한방내과학회지2019 · 제40권 제4호전이성 4기 대장암 환자의 한의기반 통합암치료를 통한 증상 호전 증례보고김종희, 박소정, 박지혜, 오현묵, 유화승대한한방내과학회 · 대한한방내과학회지2020 · 제41권 제6호한방치료 후 NK세포 활성도의 호전을 보인 암환자 증례보고 3례김은지, 박찬란, 손창규, 이남헌, 조정효대한한방내과학회 · 대한한방내과학회지2021 · 제42권 제3호‘표준치료를 받은 폐암 환자의 한방병원 입원 임상경로’개발 및 적용고금영, 김동현, 박소정, 유화승, 윤성훈, 최준용, 하기태한의병리학회 · 동의생리병리학회지2023 · 제37권 제6호세포독성 항암화학요법 유발 호중구 감소증에 대하여 복합 한방 치료를 병행하여 호전된 비소세포폐암 환자 1례유재환, 이민준, 진수현, 최대준대한한방내과학회 · 대한한방내과학회지2025 · 제46권 제3호

이 간행물의 다른 논문 (10건)